Bicycle Therapeutics (BCYC) Total Liabilities (2018 - 2026)

Bicycle Therapeutics' Total Liabilities history runs 9 years deep, the most recent figure standing at $98.1 million for Q1 2026.

• Quarterly Total Liabilities fell 31.68% year-over-year to $98.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.1 million (down 31.68% YoY) and the FY2025 annual result came in at $107.6 million, down 34.3% from the prior year.
• Total Liabilities was $98.1 million for Q1 2026 at Bicycle Therapeutics, down from $107.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $234.1 million in Q2 2023 and bottomed at $98.1 million in Q1 2026.
• A 5-year average of $162.3 million and a median of $163.3 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities soared 74.56% — and 2025, when it tumbled 34.3%.
• Bicycle Therapeutics' Total Liabilities stood at $139.8 million in 2022, then soared by 60.49% to $224.4 million in 2023, then slipped by 27.01% to $163.8 million in 2024, then tumbled by 34.3% to $107.6 million in 2025, then slipped by 8.87% to $98.1 million in 2026.
• Business Quant data shows BCYC's Total Liabilities at $98.1 million in Q1 2026, $107.6 million in Q4 2025, and $145.5 million in Q3 2025.